Form 4 for AMGN Amgen
Accepted 2026-08-07 18:47:09 ET · period of report 2026-08-06 · accession 0000318154-26-000130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-07 18:47 | 2026-08-06 | AMGN | Miller Derek | SVP, Human Resources | M - OptEx | $169.56 | +3,890 | 14.3K | +37% | +$659.6K |
| DM | 2026-08-07 18:47 | 2026-08-06 | AMGN | Miller Derek | SVP, Human Resources | S - Sale+OE | $402.54 | -3,890 | 12.5K | -24% | -$1.57M |
| DM | 2026-08-07 18:47 | 2026-08-06 | AMGN | Miller Derek | SVP, Human Resources | M - OptEx | $0.00 | -3,890 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-06 | M | A | 2,069 | $162.60 | 14,531 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-06 | S | D | 2,069 | $402.54 | 12,462 | D | — | — | (F1) Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options. (F2) The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| 3 | Common | Common Stock | 2026-08-06 | M | A | 1,821 | $177.46 | 14,283 | D | — | — | |
| 4 | Common | Common Stock | 2026-08-06 | S | D | 1,821 | $402.54 | 12,462 | D | — | — | (F1) Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options. (F2) The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. (F3) These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| 5 | Derivative | Nqso (Right to Buy) | 2026-08-06 | M | D | 2,069 | $0.00 | 0 | D | $162.60 · 2019-05-01 to 2027-05-02 | 2,069 Common Stock | |
| 6 | Derivative | Nqso (Right to Buy) | 2026-08-06 | M | D | 1,821 | $0.00 | 0 | D | $177.46 · 2020-04-27 to 2028-04-27 | 1,821 Common Stock |